![[current-page:title] logo](/sites/default/files/styles/logo/public/default_images/_no-logo.png?itok=8OH0tuUw){kind=logo}
Corporate information
Registration country
Company type
A biotechnology company, develops medicines to treat cancer and fibrotic diseasesFunding rounds
Acquisition USD 225,000,000
USD 225,000,000 ( ) at USD 225,000,000 pre-money valuation
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Gilead Sciences Inc | A biopharmaceutical company that discovers, develops and commercializes therapeutics. | USD 225,000,000 (USD 225,000,000) |
| Investor | Profile | Country | |
|---|---|---|---|
|
Duff Ackerman & Goodrich Ventures (DAG Ventures) | A mid-stage venture capital partnership with a service-oriented mindset. | |
|
Healthcare Ventures LLC | Venture capital firm focused on life sciences companies in pre-clinical and early clinical stage. | |
|
Kleiner Perkins Caufield & Byers LLC (KPCB) | Venture capital firm. | |
|
Northgate Capital |
Investment activity status
Active investor